"Based in New York City, Aetion is a leading health care technology company that delivers the real-world analytics and evidence needed for pharmaceutical developers and purchasers to thrive in value-based care. With its patented rapid-cycle analytics technology, the platform uses the everyday clinical and financial interactions of the health care system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and a big data pioneer, Aetion enables biopharma companies and payers to collaborate in real-time to develop therapeutic insights so that patients get the most clinically effective – and cost-effective – care."

During the past decade, Aetion, Inc. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Aetion, Inc." are "Pulmonary Disease, Chronic Obstructive" (2 trials), "SARS-CoV-2" (2 trials), "COVID-19" (1 trials) and "Coronavirus" (1 trials). Many other conditions were trialed in "Aetion, Inc." in a lesser frequency.

Most popular intervention types in "Aetion, Inc." are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone Oral" (1 trials), "Initiation of IL6Ri (tocilizumab or sarilumab) versus JAKi (baricitinib or tofacitinib) added to systemic corticosteroids of interest (CSI)" (1 trials), "Olodaterol/Tiotropium Bromide" (1 trials), "Sp(t)iolto® Respimat®" (1 trials) and "Tiotropium bromide + Olodaterol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aetion, Inc." are 6 trials for "All" genders.

Currently, there are NaN active trials in "Aetion, Inc.". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Aetion, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aetion, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".